Autosomal dominant popliteal pterygium syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:1300OMIM:119500Q87.2
Who is this for?
Show terms as
2Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Autosomal dominant popliteal pterygium syndrome (PPS), also known as facio-genito-popliteal syndrome, is a rare congenital disorder characterized by a combination of orofacial, musculoskeletal, and genitourinary anomalies. It is caused by mutations in the IRF6 gene, the same gene implicated in Van der Woude syndrome, and is inherited in an autosomal dominant pattern with variable expressivity. PPS is allelic to Van der Woude syndrome but generally presents with a broader and more severe spectrum of features. The hallmark feature of popliteal pterygium syndrome is the presence of webbing (pterygia) behind the knees (popliteal fossae), which can restrict leg movement and range from mild skin folds to extensive webs containing muscles, nerves, and blood vessels. Other key clinical features include cleft lip and/or cleft palate, lip pits (small depressions on the lower lip), syndactyly (webbing of fingers or toes), and genital anomalies such as cryptorchidism or scrotal malformations in males and labial hypoplasia in females. Additional findings may include ankyloblepharon filiforme adnatum (thin bands of tissue connecting the upper and lower eyelids), oral synechiae (bands connecting the upper and lower jaws), hypoplastic nails, and a distinctive pyramidal fold of skin over the hallux toenail. Treatment of popliteal pterygium syndrome is symptomatic and multidisciplinary. Surgical intervention is typically required to release popliteal webbing and improve mobility, repair cleft lip and palate, and address genital anomalies. Careful surgical planning is essential because the popliteal pterygia may contain the sciatic nerve or popliteal vessels. Orthopedic, plastic surgical, and urological specialists are often involved in the management of affected individuals. Genetic counseling is recommended for affected families given the autosomal dominant inheritance pattern and the 50% recurrence risk for offspring of affected individuals.

Also known as:

Clinical phenotype terms— hover any for plain English:

Hypoplastic labia majoraHP:0000059Nonketotic hyperglycinemiaHP:0008288Fibrous syngnathiaHP:0009754
Inheritance

Autosomal dominant

Passed on from just one parent; each child has about a 50% chance of inheriting it

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Autosomal dominant popliteal pterygium syndrome.

View clinical trials →

No actively recruiting trials found for Autosomal dominant popliteal pterygium syndrome at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Autosomal dominant popliteal pterygium syndrome community →

Specialists

2 foundView all specialists →
KP
Kristian Borg, MD, Prof
HAUPPAUGE, NY
Specialist
PI on 1 active trial
SA
Sophitnapa Tanasittiboon, Anesthesiologist
Specialist
PI on 1 active trial

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Autosomal dominant popliteal pterygium syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Autosomal dominant popliteal pterygium syndromeForum →

No community posts yet. Be the first to share your experience with Autosomal dominant popliteal pterygium syndrome.

Start the conversation →

Latest news about Autosomal dominant popliteal pterygium syndrome

No recent news articles for Autosomal dominant popliteal pterygium syndrome.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Autosomal dominant popliteal pterygium syndrome

What is Autosomal dominant popliteal pterygium syndrome?

Autosomal dominant popliteal pterygium syndrome (PPS), also known as facio-genito-popliteal syndrome, is a rare congenital disorder characterized by a combination of orofacial, musculoskeletal, and genitourinary anomalies. It is caused by mutations in the IRF6 gene, the same gene implicated in Van der Woude syndrome, and is inherited in an autosomal dominant pattern with variable expressivity. PPS is allelic to Van der Woude syndrome but generally presents with a broader and more severe spectrum of features. The hallmark feature of popliteal pterygium syndrome is the presence of webbing (pter

How is Autosomal dominant popliteal pterygium syndrome inherited?

Autosomal dominant popliteal pterygium syndrome follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Autosomal dominant popliteal pterygium syndrome typically begin?

Typical onset of Autosomal dominant popliteal pterygium syndrome is neonatal. Age of onset can vary across affected individuals.

Which specialists treat Autosomal dominant popliteal pterygium syndrome?

2 specialists and care centers treating Autosomal dominant popliteal pterygium syndrome are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.